BSL — Bhayani Securities (Pvt) Ltd.
PSYL logo

Rs 296.14 ▲ +26.92 (+10.00%)As of close

View PSYL share price

Pakistan Synthetics Limited: Transmission of Annual Report for the Year Ended June 30, 2026

ReportNEUTRAL

Key facts

Revenue
PKR 15,666.24M, down from PKR 16,872.30M in 2025.
Net Profit (PAT)
PKR 811.45M, a significant increase from PKR 367.45M in the previous year.
Earnings Per Share (EPS)
PKR 5.85, up from PKR 2.65 in 2025.
Balance Sheet Highlights
Total assets increased to PKR 12,668.43M from PKR 11,198.51M. Shareholder equity rose to PKR 5,438.96M from PKR 4,627.97M.
Future Outlook
The company is exploring alternative raw material sources and pursuing renewable energy solutions to enhance operational efficiency.

Pakistan Synthetics Limited has transmitted its Annual Report for the year ended June 30, 2026, detailing its financial performance and operational insights.

  • Revenue: PKR 15,666.24M, down from PKR 16,872.30M in 2025.
  • Net Profit (PAT): PKR 811.45M, a significant increase from PKR 367.45M in the previous year.
  • Earnings Per Share (EPS): PKR 5.85, up from PKR 2.65 in 2025.
  • The report indicates a stable gross margin despite rising raw material costs, with gross profit rising to PKR 2,036.11M from PKR 1,976.02M.
  • Operating profit from core business operations grew by 11.7% year-on-year.
  • The company did not declare any cash dividends for the year, focusing on long-term financial commitments.
  • The financial statements were audited by BDO Ebrahim & Co., confirming compliance with applicable standards.
  • Balance Sheet Highlights: Total assets increased to PKR 12,668.43M from PKR 11,198.51M. Shareholder equity rose to PKR 5,438.96M from PKR 4,627.97M.
  • The company maintains a credit rating of "A-" from PACRA.
  • Future Outlook: The company is exploring alternative raw material sources and pursuing renewable energy solutions to enhance operational efficiency.

About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange, per our editorial policy and data methodology. A summary for information, not investment advice — the original filing is the authoritative record.

Trade PSYL with BSL

Act on this filing with live PSX data, research support, and a broker built for it.

Open an account